If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp E Regulatory News (PEY)

Share Price Information for Partners Grp E (PEY)

Share Price is delayed by 15 minutes
Get Live Data
7.46    0.02 (0.27%)
Bid:
7.38
Ask:
7.46
Spread: 0.08 (1.084%)
Market Cap: €500.25m
PEY Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp E Share Chart

PGPE Ltd publishes May NAV

Today 07:00

RNS Number : 4831L
Partners Group Private Equity Ltd
08 July 2026
 

(LSE: PEY/PEYS)

 

Partners Group Private Equity Limited

 

NAV decreased by 0.7% in May

 

 

· NAV decreased to EUR 11.84 per share, corresponding to EUR 801.71 million

· Portfolio revaluations (-0.7%) partially offset by positive currency movements (+0.2%)

· PGPE Ltd declared a first interim dividend of EUR 0.325 per share, with the shares trading ex-dividend during the month

 

During May, the NAV of PGPE Ltd declined by 0.7%, primarily due to the revaluation of Emeria, a leading European real estate services provider. This was partially offset by positive currency movements, with the USD appreciating over the reporting period.

 

Emeria's operating performance improved in 2025 following a prolonged period of macro headwinds. However, Q1 2026 was softer, reflecting the impact of businesses divested in 2025, prior-year client churn in its French Residential Real Estate Services ("RRES") segment, and some renewed macroeconomic pressure. As a result, Emeria's valuation declined in May 2026, driven by the weaker operating performance and a modest reduction in the valuation multiple applied, in line with public market comparables. The company continues to roll out its new operating model within the French RRES business, alongside ongoing initiatives to support organic growth. Against this backdrop, Partners Group remains supportive of Emeria and is aligned with management and the board on strategy, and the company does not currently face liquidity concerns.

 

Meanwhile, the portfolio's younger vintages remain an important source of value creation. More recent investments, such as Rosen Group and MPM Products, undertaken in 2024 and 2025 respectively, have shown encouraging early operating momentum, supported by resilient market positioning, and the application of Partners Group's value creation approach from the outset of ownership.

 

PGPE Ltd maintained a robust liquidity profile at month-end, with cash and cash equivalents of EUR 68.8 million as of 31 May 2026. Following the payment of the first interim dividend in June, the Company retains a comfortable cash position, complemented by its fully undrawn EUR 150.0 million credit facility, which provides additional balance sheet flexibility.

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd is an investment holding company founded in 1999 and domiciled in Guernsey. It invests in private equity direct investments. PGPE Ltd is managed in its investment activities by Partners Group, one of the largest firms in the global private markets industry, with USD 185 billion in investment programs under management in private markets, of which USD 86 billion is in private equity. Partners Group itself is listed on the Swiss Stock Exchange (ticker: PGHN). PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield. PGPE Ltd is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro quote; PEYS for the Sterling quote).

 

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

Investor relations contact:

Andreea Mateescu

Phone: +41 41 784 66 73

E-mail:andreea.mateescu@partnersgroup.com

 

Media relations contact:

media@partnersgroup.com

 

Registered Number: 35241 LEI: 54930038LU8RDPFFVJ57

Notes:

1. Note that references in this announcement to Partners Group Private Equity Limited have been abbreviated to "PGPE Ltd" or "the Company". References to Partners Group AG have been abbreviated to "Partners Group" or "the Investment Manager".

2. This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Partners Group Private Equity Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

3. This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of PGPE Ltd's website nor the contents of any website accessible from hyperlinks on PGPE Ltd's website (or any other website) are incorporated into, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGXGDRDDGDGLI
Date   Source Headline
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSNAV increases by 2.3% in July
25th Aug 20207:00 amRNSPartners Group to sell PCI Pharma Services
17th Aug 20207:00 amRNSPrincess publishes Half-Year Report 2020
7th Aug 20207:00 amRNSPrincess Q2 2020 Results Presentation
3rd Aug 20207:00 amRNSTotal Voting Rights
28th Jul 20207:00 amRNSNew Investment Management Agreement
24th Jul 20207:00 amRNSNAV increases by 2.9% in June
10th Jul 20204:45 pmRNSRevision to Dividend Payment Date
1st Jul 20207:00 amRNSCompliance with Model Code
1st Jul 20207:00 amRNSTotal Voting Rights
25th Jun 20207:00 amRNSNAV increases by 3.0% in May
23rd Jun 20207:00 amRNSDividend Declaration
11th Jun 20207:00 amRNSExit of Action closed
5th Jun 20207:00 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSTotal Voting Rights
27th May 20203:00 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSNAV increases by 5.6% in April
22nd May 20207:30 amRNSHolding(s) in Company
12th May 20207:00 amRNSPrincess Q1 2020 Results Presentation
6th May 20201:52 pmRNSResult of Annual General Meeting
1st May 20207:00 amRNSPrincess publishes March NAV
1st May 20207:00 amRNSPrincess Statement of COVID-19 & dividend guidance
1st May 20207:00 amRNSTotal Voting Rights
28th Apr 20205:38 pmRNSDisclosure of Rights Attached to Equity Shares
3rd Apr 20204:00 pmRNSNotice of AGM
1st Apr 20207:00 amRNSCompliance with Model Code
1st Apr 20207:00 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSPrincess publishes February NAV
26th Mar 20207:00 amRNSPrincess - statement on impact of Covid-19
18th Mar 20208:28 amRNSCredit Facility Extension
16th Mar 202012:09 pmRNSSecond Price Monitoring Extn
16th Mar 202012:04 pmRNSPrice Monitoring Extension
11th Mar 202012:30 pmRNSAnnual Financial Report
2nd Mar 20207:00 amRNSTotal Voting Rights
26th Feb 20207:00 amRNSNAV increases by 0.2% in January
18th Feb 20207:00 amRNS4th Quarter 2019 Results
3rd Feb 20207:00 amRNSTotal Voting Rights
27th Jan 20207:00 amRNSNAV increases by 5.7% in December
9th Jan 20205:02 pmRNSNotification of interests of Directors
2nd Jan 20207:00 amRNSCompliance with Model Code
2nd Jan 20207:00 amRNSTotal Voting Rights
23rd Dec 20197:00 amRNSNAV increases by 0.5% in November
2nd Dec 20197:00 amRNSTotal Voting Rights
26th Nov 20197:00 amRNSPrincess publishes October NAV
20th Nov 20197:00 amRNSPrincess Private Equity publishes Q3 report 2019
15th Nov 201911:09 amRNSPartners Group to sell stake in Action
12th Nov 20197:00 amRNS3rd Quarter 2019 Results
11th Nov 20194:30 pmRNSDividend Declaration
5th Nov 20197:00 amRNSReminder: Princess Q3 2019 Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.